drugset / Trial / NCT00489073

Duloxetine Versus Placebo for Fibromyalgia

NCT00489073

Phase 3 Completed 345 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with fibromyalgia.

Timeline

Start
2002-11
Primary completion
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule

Indications